Browsing publications by Dr Britta Vormoor

Newcastle AuthorsTitleYearFull text
Dr Britta Vormoor
Dr Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Dr Britta Vormoor
Yvonne Schlosser
Dr Helen Blair
Sarah Wilkinson
Professor Herbie Newell
et al.
Inhibition of DNA-Repair Enzymes (DNA-Pk and Parp) to Sensitize Ewing Sarcoma to Chemo-And Radiotherapy2015
Dr Jeyanthy Eswaran
Dr Paul Sinclair
Professor Olaf Heidenreich
Professor Julie Irving
Dr Lisa Russell
et al.
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia2015
Dr Britta Vormoor
Henrike Knizia
Michael Batey
Dr Petra Dildey
Abhishek Sharma
et al.
Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging2014
Dr Britta Vormoor
Dr Yan Zhao
Professor Herbie Newell
Evaluating the activity of the p53-MDM2 inhibitor NDD0005 in Ewing sarcoma2014
Dr Britta Vormoor
Professor Nicola Curtin
Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma2014
Dr Britta Vormoor
Sarah Wilkinson
Fiona Harvey
Professor Ruth Plummer
Professor Nicola Curtin
et al.
Ewing's Sarcoma Cells Can Be Sensitized to Temozolomide and to a Lesser Extent to Radiotherapy by Co-treatment with a PARP-inhibitor (AG014699)2012
Dr Britta Vormoor
Professor Nicola Curtin
Professor Steven Clifford
Sensitisation of paediatric solid tumours to DNA-damaging chemotherapy by inhibition of DNA-dependent protein kinase (PRKDC)2010
Dr Britta Vormoor
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 952005
Dr Britta Vormoor
Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture2003
12